Radiation-induced acute myeloid leukemias (AMLs) in the mouse are characterized by chromosome 2 deletions. Previous studies showed that a minimal deleted region (mdr) of ϳ6.5 cM is lost from one homologue in chromosome 2-deleted AMLs. An AML tumor suppressor gene is proposed to map within this mdr.
Haploinsufficiency and reduced expression of genes localized to the 8p chromosomal region in human prostate tumors
✍ Scribed by Hassan Chaib; James W. MacDonald; Robert L. Vessella; Joseph G. Washburn; Janna E. Quinn; Austin Odman; Mark A. Rubin; Jill A. Macoska
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 328 KB
- Volume
- 37
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Cytogenetic and molecular studies have suggested that deletion or rearrangement of sequences that map to the short arm of chromosome 8 may be permissive for tumorigenesis in several organ systems, and in human prostate tumors in particular. In this study, we hypothesized that genes deleted for one copy and localized to the 8p chromosomal region may be transcriptionally down‐regulated or ablated in affected human prostate tumor tissues. To test this hypothesis, we used cDNA microarray analysis to determine the transcriptional profiles for 259 transcribed sequences mapping to the 8p chromosomal region for seven human prostate tumor xenografts, completely characterized for numerical and structural alterations on chromosome 8, and five normal human prostate tissues. These experiments identified 33 genes differentially expressed between normal and malignant prostate tissues, the majority of which (28/33, 85%) were transcriptionally down‐regulated in malignant compared to normal human prostate tissues. These findings, that haploinsufficiency and transcriptional down‐regulation for genes mapping to 8p are largely coincident in human prostate tumors, should provide a powerful tool for the identification of tumor‐suppressor genes associated with human prostate cancer initiation and progression. © 2003 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES